Table 5. Glutamic acid repeat variant frequency of of ALMS1 gene in patients and control groups.
| Alleles | Frequency | ||
|---|---|---|---|
| EOCAD (%) | EOMI (%) | Controls (%) | |
| A13 | 3 (0.24%) | 1 (0.16) | 2 (0.15) |
| A14 | 369 (29.47) | 233 (36.64) | 365 (26.49) |
| A15 | 29 (2.32) | 13 (2.04) | 39 (2.83) |
| A16 | 95 (7.59) | 57 (8.96) | 91 (6.60) |
| A17 | 594 (47.44) | 257 (40.41) | 686 (49.78) |
| A18 | 96 (7.67) | 45 (7.08) | 112 (8.13) |
| A19 | 24 (1.92) | 12 (1.89) | 27 (1.96) |
| A20 | 40 (3.19) | 18 (2.83) | 52 (3.77) |
| A21 | 2 (0.16%) | — | 3 (0.22) |
| A22 | — | — | 1 (0.07) |
| Short* | 496 | 304 | 497 |
Abbreviations: EOCAD, early-onset coronary artery disease; EOMI, early-onset myocardial infarction.